Cheatham Platinum CP Stent System
FDA PMAClass III (US FDA PMA)
by NuMED, Inc.
Identity
- Trade Name
- CHEATHAM PLATINUM (CP) STENT SYSTEM (Covered CP Stent, Covered Mounted CP Stent, CP Stent, Mounted CP Stent) FDA PMA
- Generic Name
- Aortic stent FDA PMA
Identifiers
- PMA Number
- P150028 FDA PMA
- FDA Product Code
- PNF FDA PMA
- Models / Variants
- Covered CP Stent FDA PMACovered Mounted CP Stent FDA PMACP Stent FDA PMAMounted CP Stent FDA PMA
Classification
- Device Class
- Class III FDA PMA
- Advisory Committee
- Cardiovascular FDA PMA
- FDA Decision
- APPR Approved FDA PMA
The Cheatham Platinum CP Stent System is an aortic stent designed for the treatment of native and recurrent coarctation of the aorta. The system includes the CP Stent, Mounted CP Stent, Covered CP Stent, and Covered Mounted CP Stent, which are used when balloon angioplasty is contraindicated or predicted to be ineffective.
These stents are indicated for use in the aortic isthmus or the first segment of the descending aorta, provided there is adequate size and patency of at least one femoral artery. The covered versions are specifically indicated for cases involving aortic wall injury, nearly atretic descending aorta, non-compliant stenotic segments, or genetic syndromes associated with aortic wall weakening. This device is manufactured by NuMED, Inc. and has received FDA PMA approval.
Frequently asked questions
What is the Cheatham Platinum CP Stent System used for?
The system is indicated for the treatment of native and recurrent coarctation of the aorta in the aortic isthmus or the first segment of the descending aorta where balloon angioplasty is not suitable.
What is the difference between the CP Stent and the Covered CP Stent?
The Covered CP Stent and Covered Mounted CP Stent are indicated for more complex cases, such as acute or chronic aortic wall injury, nearly atretic descending aorta, non-compliant stenotic segments, or conditions associated with aortic wall weakening.
Are there specific anatomical requirements for using this stent?
Yes, the procedure requires that there is adequate size and patency of at least one femoral artery to allow for the delivery of the stent system.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: The CP stent—short, long, covered—for the treatment of aortic ..., Covered CP Stent™ - B. Braun Interventional Systems, [PDF] summary of safety and effectiveness data (ssed), B. Braun Will Distribute NuMed's Newly Approved Cheatham ..., Stents | NuMED For Children
Authorization Coverage (2 countries)
Regulatory Authorizations
MDD
FDA_PMA
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA PMA | European Union | MDD | — | Class III | Pending data |
| FDA PMA | United States | FDA_PMA | P150028 | Class III | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- NuMED, Inc.
Sources (1)
- FDA PMA P150028 24 fields · synced Oct 6, 2026